Drug Sponsors Should Include Women In QT Studies, CERT’s Woosley Says
QT interval prolongation studies should include more women because of gender differences in cardiac sensitivity to drugs, University of Arizona Center for Education and Research on Therapeutics (AZCERT) Director Raymond Woosley said
You may also be interested in...
A pilot program designed to track drug safety through a pharmacy-based electronic adverse event system is under development by the Critical Path to Accelerate Therapies Institute as part of a partnership with FDA
Industry wants FDA to make available a database of results from QT prolongation studies
A Journal of the American Pharmaceutical Association editorial endorses the forced switch of prescription antihistamines to over-the-counter status.